Optimal Medical Treatment Under-used in Vascular Peripheral Disease

Less than half of patients undergoing endovascular revascularization for peripheral artery disease to their lower limbs are discharged with optimal medical treatment. 

Subutilización del tratamiento médico en enfermedad vascular periférica

Their traditional risk factors are predictors of a more comprehensive treatment; however, women, patients with higher risk of thrombosis, and those more likely to lose a lower limb, are far from being treated optimally.

When reading these outcomes, we tend to believe most physicians think women are not at risk and, on the opposite side of the spectrum, those at risk of amputation are too far gone to even try.

The aim of this study was to look into indications at discharge of patients treated with lower limb endovascular intervention.

According to guidelines, optimal medical treatment is prescribed at discharge when patients are under antiplatelet therapy, statins and one inhibitor of the angiotensin convertor enzyme (ACEI) or an angiotensin receptor blocker (ARB). 


Read also: More Evidence for Short Term DAPT: Approaching “the Class Effect”.


Of the 12316 patients included, only 47.4% (n=5844) were discharged with optimal medical treatment. Most patients were on antiaggregants (95.2%), many on statins (83.5%) and a few on ACEI or ARB (55.8%).

80.5% of patients had a class I indication for antiaggregants. 

At multivariable analysis, it was seen that female sex, old age, kidney failure, critical lower limb ischemia, and cardiac failure were predictors of NO optimal medical treatment, against guideline recommendation. 


Read also: Pleiotropic Effect of Metoprolol: Different From other B-blockers.


On the flipside, hypertension, diabetes, heart disease and revascularization procedures were positive predictors of optimal medical treatment. 

Conclusion

Less than half of patients undergoing endovascular lower limb revascularization are discharged with optimal medical treatment against guideline recommendation. Both patients and physicians should make a serious effort to close this gap.  

Original Title: Predictors of Underutilization of Medical Therapy in Patients Undergoing Endovascular Revascularization for Peripheral Artery Disease.

Reference: S. Elissa Altin et al. J Am Coll Cardiol Intv 2020;13:2911–8.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....